The gastric cancer treatment controversy

Journal of Clinical Oncology

Volumn 21, Issue 12, 2003, Pages 2234-2236

  Van De Velde, Cornelis J H ^a   Peeters, Koen C M J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; FLUOROURACIL; MITOMYCIN; ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; EDITORIAL; HUMAN; LYMPH NODE DISSECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SENTINEL LYMPH NODE BIOPSY; SPLENECTOMY; STOMACH CANCER; TREATMENT OUTCOME; ADJUVANT CHEMOTHERAPY; JAPAN; LYMPHADENECTOMY; MORTALITY; MULTIMODALITY CANCER THERAPY; NOTE; STOMACH TUMOR; SURVIVAL RATE; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; JAPAN; LYMPH NODE EXCISION; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS; STOMACH NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0038826050     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.91.138     Document Type: Editorial

References (19)

1. Maruyama K, Sasako M, Kinoshita T, et al. Should systematic lymph node dissection be recommended for gastric cancer? Eur J Cancer 34:1480-1490, 1998
2. Nashimoto A, Nakajima T, Furukawa H, et al: Randomized Trial of Adjuvant Chemotherapy With Mitomycin, Fluorouracil and Cytosine Arabinoside Followed by Oral Fluorouracil in Serosa Negative Gastric Cancer: Japan Clinical Oncology Group 9206-1. J Clin Oncol 21:2282-2287, 2003
3. Polychemotherapy for early breast cancer: An overview of the randomized trials-Early Breast Cancer Trialists' Collaborative Group. Lancet 352:930-942, 1998
4. Cuschieri A, Weeden S, Fielding J, et al. Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial-Surgical Co-Operative Group. Br J Cancer 79:1522-1530, 1999.
5. Bonenkamp JJ, Hermans J, Sasako M, et al. Extended lymph-node dissection for gastric cancer: Dutch Gastric Cancer Group. N Engl J Med 340:908-914, 1999
6. Sasako M, Maruyama K, Kinoshita T, et al. Quality control of surgical technique in a multicenter, prospective, randomized, controlled study on the surgical treatment of gastric cancer. Jpn J Clin Oncol 22:41-48, 1992
7. Bunt TM, Bonenkamp HJ, Hermans J, et al. Factors influencing noncompliance and contamination in a randomized trial of "Western" (r1) versus "Japanese" (r2) type surgery in gastric cancer. Cancer 73:1544-1551, 1994
8. Bonenkamp JJ, Songun I, Hermans J, et al. Randomized comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 345:745-748, 1995
9. Bozzetti F, Marubini E, Bonfanti G, et al. Subtotal versus total gastrectomy for gastric cancer: Five-year survival rates in a multicenter randomized Italian trial-Italian Gastrointestinal Tumor Study Group. Ann Surg 230:170-178, 1999
10. Deguili M, Sasako M, Garino M, et al. Outcome of D1 and D2 gastrectomy for gastric cancer: Preliminary results of the Italian Gastric Cancer Study Group (IGCSG) randomized controlled surgical trial. Presented at the XXXIII World Congress Int Coll Surg, Taipei, Taiwan, October 27-November 1, 2002
11. Wu CW. Preliminary results of gastric cancer surgery trials in a single institute. Presented at the XXXIII World Congress Int Coll Surg, Taipei, Taiwan, October 27-November 1, 2002
12. Bozzetti F. Principles of surgical radicality in the treatment of gastric cancer. Surg Oncol Clin N Am 10:833-854, 2001
13. Cady B. Lymph node metastases: Indicators, but not governors of survival. Arch Surg 119:1067-1072, 1984
14. Gunderson LL, Sosin H. Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8:1-11, 1982
15. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730, 2001
16. Hundahl SA, Macdonald JS, Benedetti J, et al. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment. Ann Surg Oncol 9:278-286, 2002
17. Hermans J, Bonenkamp JJ, Boon MC, et al. Adjuvant therapy after curative resection for gastric cancer: Meta-analysis of randomized trials. J Clin Oncol 11:1441-1447, 1993
18. Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: Revisiting a meta-analysis of randomized trials. Eur J Cancer 35:1059-1064, 1999
19. Weiss MM, Kuipers EJ, Postma C, et al. Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene 22:1872-1879, 2003